eMedicine Specialties > Pediatrics: General Medicine > Infectious Disease
Bacteremia
Updated: Jun 26, 2008
Introduction
Background
Bacteremia is the presence of viable bacteria in the circulating blood.1 This may or may not have any clinical significance because harmless, transient bacteremia may occur following dental work or other minor medical procedures; however, this bacteremia is generally clinically benign and self-resolving in children who do not have an underlying illness or immune deficiency or a turbulent cardiac blood flow. The concern with occult bacteremia is that it could progress to a more severe local or systemic infection if left untreated. Most episodes of occult bacteremia spontaneously resolve, and serious sequelae are increasingly uncommon. However, serious bacterial infections occur, including pneumonia, septic arthritis, osteomyelitis, cellulitis, meningitis, and sepsis, possibly resulting in death.2,3
Patients with occult bacteremia do not have clinical evidence other than fever (a systemic response to infection).4 First described in the 1960s in young febrile children with unsuspected pneumococcal infection, bacteremia is defined as the presence of bacteria in the bloodstream of a febrile child who was previously healthy; the child does not clinically appear to be ill and has no apparent focus of infection.5,6 Occult bacteremia has been defined as bacteremia not associated with clinical evidence of sepsis (shock or purpura) or toxic appearance, underlying significant chronic medical conditions, or clear foci of infection (other than acute otitis media) upon examination in a patient who is discharged and sent home after an outpatient evaluation.2
Often, the only manifestation of occult bacteremia is fever or a minor infection (eg, otitis media, upper respiratory tract infection).4 Therefore, in a busy clinic or emergency department, infants and young children with occult bacteremia are difficult to distinguish from others in the waiting-room.
Fever is common in pediatric patients. Children average 4-6 fevers by age 2 years.7 Fever also prompts many visits to the pediatric clinic and emergency department. Approximately 8-25% of doctor's visits by children younger than 3 years are for fever;4,7,8,9 65% of children younger than 3 years visit a physician for acute febrile illness.8,10
Fever is less common in infants younger than 3 months than in those aged 3 months to 3 years. Young infants may not mount a fever response and may also be hypothermic in response to illness or stress.7 Approximately 1% of infants younger than 2 months present with fever, and fever is twice as common in infants aged 1-2 months as it is in newborns younger than 1 month.7
Of all pediatric patients presenting for evaluation of fever, 20% have fever for which the source of infection is undetermined after a history and physical examination.9 Of all infants and young children who present to the hospital for any reason, 1.6% appear nontoxic, were previously healthy, are older than 3 months, and have a fever without a source (FWS).9
Bacteremia may also occur in children with focal infections or in children who have sepsis (ie, clinical evidence other than fever of a systemic response to infection). Children with sepsis generally appear ill, have an increased heart rate or respiratory rate and may have a change in temperature (typically fever, although hypothermia is often seen in very young infants and newborns). Severe sepsis results in hypotension, hypoperfusion, or organ dysfunction. Septic shock occurs in children who do not respond to adequate volume resuscitation or require vasopressors or inotropes. Although bacteria may be present in the bloodstream of children with focal infections, sepsis, severe sepsis, or septic shock, the focus of this article is occult bacteremia.
Pathophysiology
Much of the pathophysiology of occult bacteremia is not fully understood. The presumed mechanism begins with bacterial colonization of the respiratory passages or other mucosal surface; bacteria may egress into the bloodstream of some children because of host-specific and organism-specific factors. Once viable bacteria have gained access to the bloodstream, they may be spontaneously cleared, they may establish a focal infection, or the infection may progress to septicemia; the possible sequelae of septicemia include shock, disseminated intravascular coagulation, multiple organ failure, and death.4,11
Often, fever is the only presenting sign in patients with occult bacteremia and is defined as increased temperature caused by resetting the thermoregulatory center in the hypothalamus by action of cytokines.7 The cytokines may be produced in response to viral or bacterial pathogens or by immune complexes. An increased temperature does not always represent a fever. Hyperthermia may also be due to increased heat production as occurs in exercise or decreased heat loss as occurs in overbundling, neither of which involves resetting of the hypothalamic thermostat.
A child's immune system helps determine which bacteria gain initial access to the bloodstream, whether bacteremia spontaneously resolves or progresses to serious bacterial illness, and whether cytokines are produced to mount a fever response. The risk of life-threatening bacterial disease is greatest in young infants when their immune system is least mature; they have poor immunoglobulin G (IgG) antibody response to encapsulated bacteria and decreased opsonin activity, macrophage function, and neutrophil activity.12,13
Clearly, some children are more susceptible to bacterial infection, which may initially be uncomplicated bacteremia but could rapidly lead to more serious complications. Immunosuppression due to neoplastic disease or its treatment or defects in antibody responses or neutrophil responses predispose certain children to invasive infection. Bacteremia should be considered, with a low threshold for evaluation and treatment, in patients with impaired immunity or invasive medical devices such as indwelling central venous lines.
The pathogens implicated in occult bacteremia change in response to vaccination against the common pathogenic strains. These changes govern the choices for empiric therapy of suspected bacteremia.
Frequency
United States
The risk of bacteremia has been studied by categorizing infants and young children based on age, appearance, temperature, laboratory criteria, numerous low-risk criteria based on a combination of these factors, and past medical history. These studies are part of an ongoing attempt to decide which children require evaluation and treatment and which children can be safely observed without intervention.
Numerous investigators have loosely and specifically defined the terms toxic and lethargic (see Physical). A child who is toxic or lethargic is generally described as making poor eye contact; having poor interactions with parents and the environment; and showing signs on global assessment of poor perfusion, hypoventilation or hyperventilation, or cyanosis.8
In children younger than 3 months, the risk of bacteremia is 1.2-2% in infants who are not toxic and 10-11% in infants who are toxic.8,14 In children aged 3-36 months who are toxic, the risk of bacteremia or serious bacterial infection ranges from 10-90%, depending on criteria.8,10
Most studies designed to determine the relationship between temperature and risk of occult bacteremia define fever as a temperature of at least 38°C (100.4°F) in infants younger than 3 months and at least 39°C (102.2°F) in children aged 3-36 months. Because these studies were designed to predict occult bacteremia, they include children who have only FWS, which is defined as an acute febrile illness in which the etiology is not apparent after history is obtained and a careful physical examination is performed.10
Numerous studies published in the early 1990s found that 2-15% of febrile infants younger than 3 months had bacteremia.12,15,13,16 These studies also determined that the risk of occult bacteremia in children aged 3-36 months with FWS was 2.5-11%.4,8,9,17,18 According to studies performed after the introduction of the conjugate Haemophilus influenzae type b (Hib) vaccine, the risk of occult bacteremia was 1.5-2.3% in children aged 3-36 months with FWS.19,20,21
Clinical trials and postlicensure studies suggest that the 7-valent conjugate pneumococcal vaccine is 90% effective in preventing invasive disease caused by Streptococcus pneumoniae. Widespread use has significantly decreased the overall risk of occult bacteremia, especially with regards to vaccine-specific strains of streptococcus.9,22,23
The appearance of the nonvaccine pneumococcus strain 19A, which has been responsible for some particularly invasive (and drug-resistant) infections, is a concern. This is discussed in more detail below.
International
According to the World Health Organization, at least 6 million children die each year of pneumococcal infections (eg, pneumonia, meningitis, bacteremia); most of these fatalities occur in developing countries.24
Mortality/Morbidity
The natural history, morbidity, and mortality associated with occult bacteremia alone are not clearly understood. In prospective studies of occult bacteremia, although many children were initially observed untreated, all were given antibiotics once blood culture findings became positive for known bacterial pathogens.25 The widespread adoption of vaccines to the most common childhood bacteria pathogens (H influenzae and S pneumoniae) have further complicated assessment because contemporary data are not directly comparable to historical studies.In studies performed before the introduction of the Hib conjugate vaccine, children with untreated bacteremia had an 18-21% risk of developing persistent bacteremia and a 2-15% risk of developing important focal infections such as meningitis.4,8,10,26
Because widespread use of the Hib vaccine has virtually eliminated invasive Hib disease in the developed world, recent reviews, analyses, and studies have focused on invasive S pneumoniae disease. Children with occult pneumococcal bacteremia have a 6-17% risk of persistent bacteremia, a 2-5.8% risk of meningitis, and a 6-10% risk of other focal complications.4,2,8,27,10,21
Of all focal infections that develop because of pneumococcal bacteremia, pneumococcal meningitis carries the highest risk for significant morbidity and mortality, including a 25-30% risk of neurologic sequelae such as deafness, mental retardation, seizures, and paralysis.25,9 The mortality rate of pneumococcal meningitis is 6.3-15%, and the overall mortality rate of pneumococcal bacteremia is 0.8%.25,9,23
Neisseria meningitidis also causes bacteremia in infants and young children. Although the prevalence of meningococcal bacteremia is much lower than that of pneumococcal disease (see Causes), the morbidity and mortality rates are much greater. Children with meningococcal bacteremia have a 42-50% risk of developing meningitis; a 50% risk of developing serious bacterial infection such as septic shock, pneumonia, and neurologic changes; a 3% risk of developing extremity necrosis; and an overall mortality rate of 4%.4,25,9
When untreated, Salmonella bacteremia carries a 50% risk of persistent bacteremia and can cause meningitis, sepsis, and death in infants younger than 3 months or in persons who are debilitated or immunocompromised.2 However, in previously healthy children aged 3-36 months, the risk of meningitis or serious bacterial infection following Salmonella bacteremia is low.4
Race
Studies of the prevalence of bacteremia in children in diverse settings have identified no racial, geographic, or socioeconomic predisposition.4,6,11,28 However, antibiotic resistance patterns vary in different geographic regions, which may affect the treatment of children with bacteremia.
Sex
No sex-based difference in the prevalence or course of bacteremia is known.11
Age
Studies of occult bacteremia focus on children younger than 3 years. Some studies show that age does not affect the risk of developing occult bacteremia,11 whereas other analyses have found that variations in age-based risk depend on the infecting organism.
Pneumococcal bacteremia is observed in children of all ages; however, children aged 6 months to 2 years are at an increased risk.6,2,20 The prevalence of pneumococcal meningitis peaks in infants aged 3-5 months. Meningococcal bacteremia occurs most frequently in infants aged 3-12 months; the highest risk of meningococcal meningitis is in infants aged 3-5 months.2,11 The risk of Salmonella bacteremia is greatest in infants younger than 1 year, especially in those younger than 2 months.2
A seasonal variation in febrile children presenting for evaluation is recognized. The peak is from late fall to early spring in children of all ages and is likely because of respiratory and GI viral infections. Another peak occurs during the summer in infants younger than 3 months and is likely due to enteroviral infections and thermoregulation during hot weather.7 However, most studies do not specifically address seasonal variation associated with bacteremia.
Clinical
History
Many studies have been performed to determine if elements of the past medical history and history of the acute illness may help in deciding whether a given febrile child is at a high risk for bacterial infection.
The significance of history varies based on age. In neonates younger than 1 month with a fever, elements of the past medical history are not useful in determining whether the bacterial infection is serious.15 The history of the acute febrile illness is also not useful because nonspecific symptoms such as feeding intolerance, temperature instability, mild respiratory distress, or irritability may indicate a serious bacterial infection in a very young infant.13
- Duration of fever: The duration of fever at presentation has been noted to be shorter in patients whose blood culture findings eventually became positive for known bacterial pathogens (mean 18 h) than in those patients with blood culture findings negative for known bacterial pathogens (mean 25 h).11 However, this difference is not statistically significant, and screening for bacteremia based on duration of fever less than 2 days would include 80% of patients with bacteremia and 74% of those without bacteremia.25 Overall, duration of fever is inadequate to clinically identify occult bacteremia.29
- History that indicates specific illness: Although meningococcal infections are uncommon causes of bacteremia (see Causes), patients with meningococcemia are at high risk for morbidity and mortality (see Mortality/Morbidity). Knowledge of local epidemiology involving an outbreak of meningococcus, along with a history of contact with someone with known meningococcal disease, can raise clinical suspicion and help confirm an important diagnosis.25
- History that indicates risk for occult bacteremia: Numerous studies have attempted to establish elements of the history that can help distinguish which febrile infants and young children are at an increased risk for bacterial infection, including occult bacteremia.
- The Rochester criteria are formal elements of the history that have been widely accepted as indicating a decreased risk for occult bacteremia in infants aged 60 days or younger.13,14 These criteria include the following:
- Was previously healthy
- Had a term of at least 37 weeks' gestation
- Did not receive perinatal antibiotics
- Was not hospitalized longer than the mother following delivery
- Did not receive treatment for unexplained hyperbilirubinemia
- Not currently using antibiotics
- Has no previous hospitalizations
- Has no chronic or underlying illness
- Elements of the history that indicate an increased risk for occult bacteremia in infants and children after the neonatal period include the following:4,8,12,30
- Age, which determines the cutoff used to define fever
- Febrile temperature (£ 3 mo and temperature >38°C [100.4°F], 3-36 mo and temperature ³ 39-39.5°C [102.2-103.1°F])
- Current antibiotic use
- Previous hospitalizations
- Chronic or underlying illness
- Immunodeficiency (eg, hypogammaglobulinemia, sickle cell anemia, human immunodeficiency virus [HIV], malnutrition, asplenia)
- The Rochester criteria are formal elements of the history that have been widely accepted as indicating a decreased risk for occult bacteremia in infants aged 60 days or younger.13,14 These criteria include the following:
- History of underlying medical condition: A longitudinal study of invasive pneumococcal infections reported that a history of an underlying medical condition was a significant risk factor for increased mortality. Children with invasive pneumococcal infections and an underlying medical condition had a mortality rate of 3.4%, whereas previously healthy children with invasive pneumococcal infections had a mortality rate of 0.84%.23
- History of other reason for increased temperature: The history may also indicate possible explanations for increased temperature other than fever in response to an acute infection, such as recent vaccinations, overbundling, or environmental exposure to heat involving a young infant.8 A thorough evaluation for illness or infection should be performed in all febrile children before determining that increased temperature is caused by any extrinsic factor.
- History of gastroenteritis: A history of gastroenteritis should increase the clinical suspicion for Salmonella bacteremia. Salmonella is an uncommon cause of gastroenteritis, but most patients who develop Salmonella bacteremia have gastroenteritis, and 6.5% of children younger than 1 year with Salmonella gastroenteritis become bacteremic.2
- Epidemiology: Although a history of family members or frequent contacts with obvious viral syndromes such as upper respiratory infections may suggest a viral syndrome,8 children with common cold symptoms were generally not excluded from studies of occult bacteremia. Results suggest that the risk of bacteremia in febrile children is the same whether common cold symptoms are present.2
- Risk factors for invasive pneumococcal disease: Studies have evaluated the relationship between history and pneumococcal disease. Elements of history that have been associated with an increased risk of pneumococcal bacteremia include daycare attendance,2,9,31 lack of breastfeeding,9,31 and underlying illness such as sickle cell disease or acquired immunodeficiency syndrome (AIDS).9,31 Although recent antibiotic use does not affect the overall rate of infection, children who were treated with antibiotics in the last 30 days are more likely to be infected with S pneumoniae that is resistant to penicillin.31
Physical
Evaluation of a febrile infant or young child begins by establishing whether the patient truly has an FWS. Toxic or lethargic children and patients with focal infection and sepsis are appropriately treated, and children with nonfocal physical examination findings are further evaluated for occult bacteremia.8,12,30- General appearance
- Numerous investigators have formally defined the initial aspect of the physical examination, the assessment of general appearance, in an attempt to assess its utility in determining the presence of bacterial disease. The Yale Observation Scale (YOS)/Acute Illness Observation Scale (AIOS) has been widely used to assess an infant's quality of cry, reaction to parents, state variation, color/perfusion, hydration, and response to social cues in the environment.6,13 Other authors have examined irritability, consolability, and social smile.11,32
- Rigorous studies by numerous authors have found that the use of clinical scores, observation scores, social smile, and general appearance have not been clinically useful in distinguishing occult bacteremia, especially in young infants.4,11,12,29,32 General appearance based on observation scores had a sensitivity of 74% and specificity of 75% in detecting serious illness in older children;8,10 it had a sensitivity of 33% in detecting bacterial disease in infants younger than 2 months.12 General appearance had 5.2% sensitivity for detecting occult bacteremia, and social smile was 45% sensitive and 51% specific for bacteremia.32,2
- A cost-effectiveness analysis suggested that clinical judgment of general appearance (YOS <6 is low risk), with an estimated sensitivity of 28% and specificity of 82%, may be a useful screening criterion because the overall prevalence of occult pneumococcal bacteremia falls with widespread use of the conjugate pneumococcal vaccine.21
- Vital signs
- Temperature, pulse, respiratory rate, and blood pressure can be very useful in raising clinical suspicion for sepsis or pneumonia and for establishing the risk for occult bacteremia. Studies have also suggested that pulse oximetry should be used routinely as a fifth vital sign.9 In younger infants, poor perfusion as judged by a capillary-refill time of less than 2 seconds is a more sensitive measure of cardiovascular status than pulse or blood pressure in the early phase of sepsis.
- In studies of occult bacteremia, children were not excluded based on specific vital sign parameters; in very young infants, the presence of a serious bacterial infection may not significantly correlate with differences in pulse, respiratory rate, or blood pressure.15 However, tachycardia, tachypnea, or hypotension in a febrile or hypothermic infant are signs of sepsis and warrant a complete evaluation.4
- Fever defined
- Most studies designed to determine the relationship between temperature and risk of occult bacteremia define fever as a temperature of at least 38°C (100.4°F) in infants younger than 3 months and a temperature of at least 39°C (102.2°F) in children aged 3-36 months. Hypothermia may be the presenting sign of bacterial infection in young infants. One guideline defined hypothermia as a temperature less than 36°C (96.8°F).8
- Although the proper method to use when measuring temperature is continuously debated, a rectal temperature taken with a glass mercury thermometer remains the criterion standard.7 Tactile fever has been found to poorly correlate with the presence of actual fever documented by a healthcare professional using rectal or oral thermometry.33 Thus, a parent who reports a child as having a fever because the child feels warm should not be used as part of the evaluation of a infant or child. Home measurement of fever based on a thermometer reading has generally been accepted as true and accurate.
- Febrile temperature
- The upper extreme of the febrile temperature alone is inadequate to distinguish occult bacteremia; however, the risk of bacteremia has consistently been found to increase with increases in temperature.20 Studies have shown a variation in risk at given temperatures based on age; this has led to the fever cutoffs listed above. Table 1. Age, Fever, and Bacterial Infection33
Open table in new window
[ CLOSE WINDOW ]Table
Age Temperature, Degrees Celsius Rate of Bacterial Infection, % Neonates <1 mo 38-38.9 5 39-39.9 7.5 >40 18 Infants aged 1-2 mo 38-38.9 3 39-39.9 5 >40 26 Age Temperature, Degrees Celsius Rate of Bacterial Infection, % Neonates <1 mo 38-38.9 5 39-39.9 7.5 >40 18 Infants aged 1-2 mo 38-38.9 3 39-39.9 5 >40 26
Table 2. Children Aged 3-36 Months - Fever and Occult Bacteremia2,4,6,9,34Open table in new window
[ CLOSE WINDOW ]Table
Temperature, Degrees Celsius Occult Pneumococcal Bacteremia, % Positive Blood Culture, % Positive Blood Culture, % Occult Pneumococcal Bacteremia, % £ 39 Very low 1.6 1 … 39-39.4 1.2 1.6 5 … 39.5-39.7 2.5 2.8 5 … 39.8-39.9 2.5 2.8 5 … 40-40.2 3.2 3.7 5 10-10.4 40.3-40.5 3.2 3.7 5 10-10.4 40.5-40.9 4.4 3.8 12 10-10.4 >41 9.3 9.2 12 10-10.4 Temperature, Degrees Celsius Occult Pneumococcal Bacteremia, % Positive Blood Culture, % Positive Blood Culture, % Occult Pneumococcal Bacteremia, % £ 39 Very low 1.6 1 … 39-39.4 1.2 1.6 5 … 39.5-39.7 2.5 2.8 5 … 39.8-39.9 2.5 2.8 5 … 40-40.2 3.2 3.7 5 10-10.4 40.3-40.5 3.2 3.7 5 10-10.4 40.5-40.9 4.4 3.8 12 10-10.4 >41 9.3 9.2 12 10-10.4 - Children aged 2-3 years who have a temperature lower than 39.5°C have less than a 1% risk of occult pneumococcal bacteremia.2
- The upper extreme of the febrile temperature alone is inadequate to distinguish occult bacteremia; however, the risk of bacteremia has consistently been found to increase with increases in temperature.20 Studies have shown a variation in risk at given temperatures based on age; this has led to the fever cutoffs listed above. Table 1. Age, Fever, and Bacterial Infection33
- Response to antipyretics: Patients with bacterial and viral sources of infection respond similarly to antipyretics; no significant difference in temperature decrease or clinical appearance after defervescence is noted. Both groups experience the same decrease in temperature in response to antipyretic therapy.4,2,33
- Focal infection on physical examination: Thoroughly examine the patient for signs of infection of the skin, soft tissue, bone, or joints. A patient with any of these focal infections should be appropriately treated and does not require evaluation for occult bacteremia.8
- Petechiae: A febrile child with a petechial rash upon physical examination has a 2-8% risk of serious bacterial infection. The clinical suspicion for meningococcemia should be increased if a petechial rash is found.8,9 However, a prospective cohort of children with fever and petechiae found a 1.6% risk of bacteremia or sepsis and a 0.5% risk of meningococcal infection.35 The children with serious bacterial infection in this study had additional findings from the history and physical examination that suggest a bacterial cause for petechiae. These findings include ill appearance, purpura, petechiae below the nipple line, and no mechanical explanation (eg, cough, vomiting, tourniquet application) for petechiae.
- Acute otitis media or upper respiratory tract infection: An evaluation for bacteremia is warranted in children with acute otitis media or upper respiratory tract infection. In most studies of occult bacteremia, these children were included for evaluation. The results of these studies show that the risk of bacteremia is the same in children with acute otitis media or upper respiratory infection as in children without these findings.4,2,8,20,3,26
- Pneumonia
- Consider the diagnosis of pneumonia in febrile children who have no other source of infection. Specific physical examination findings such as grunting, flaring, retracting, rhonchi, wheezing, rales, and focal decreased breath sounds have 94-99% specificity for pneumonia.27 Febrile children who have none of these findings rarely have pneumonia. Studies suggest that pulse oximetry may be a more reliable predictor of pulmonary infections than respiratory rate in infants and young children; one guideline recommends that patients with oxygen saturation of less than 95% should be evaluated for pneumonia by means of chest radiography.9
- Evaluation for occult bacteremia is still warranted in febrile children with clinical or radiographic pneumonia. Mild respiratory distress may indicate a serious bacterial infection in a very young infant, and studies of occult bacteremia found that patients with pneumonia have the same prevalence of bacteremia as do patients without a focus of infection.13,2,3
- Recognizable viral infections: Although symptoms of upper respiratory tract infection should not be accepted as an explanation of fever in an infant or young child, numerous other recognizable viral infections are generally accepted as a fever source. Children with varicella, croup, gingivostomatitis, herpangina, or bronchiolitis have less than a 1% chance of concomitant bacteremia.2 A retrospective study of children with these recognizable viral syndromes found a risk of 0.2% for true pathogens and a risk of 1.4% for contaminants.36 Group A streptococcal bacteremia sporadically occurs in children with varicella, but these children are usually toxic or have focal findings.2 Physical examination findings consistent with these viral infections generally remove children from studies of bacteremia; these children should be treated for viral infection without further evaluation for occult bacteremia.4,2,36
Causes
Causes of occult bacteremia vary depending on the age of the infant or child. Very young infants most commonly acquire infections from the mother during childbirth. As a patient's age increases, a gradual shift occurs toward community-acquired infections.Table 3. Causes of Occult Bacteremia in Neonates and Infants with a Temperature of 38°C or Higher15,16,12,13,14
Open table in new window
Table
| Age | Organism* | Positive Blood Cultures, % |
|---|---|---|
| Neonates <1 mo | Group B Streptococcus | 73 |
| Escherichia coli | 8 | |
| S pneumoniae | 3 | |
| Staphylococcus aureus | 3 | |
| Enterococcus species | 3 | |
| Enterobacter cloacae | 3 | |
| Infants aged 1-2 mo | Group B Streptococcus | 31 |
| E coli | 20 | |
| Salmonella species | 16 | |
| S pneumoniae | 10 | |
| H influenzae type b | 6 | |
| S aureus | 4 | |
| E cloacae | 4 |
| Age | Organism* | Positive Blood Cultures, % |
|---|---|---|
| Neonates <1 mo | Group B Streptococcus | 73 |
| Escherichia coli | 8 | |
| S pneumoniae | 3 | |
| Staphylococcus aureus | 3 | |
| Enterococcus species | 3 | |
| Enterobacter cloacae | 3 | |
| Infants aged 1-2 mo | Group B Streptococcus | 31 |
| E coli | 20 | |
| Salmonella species | 16 | |
| S pneumoniae | 10 | |
| H influenzae type b | 6 | |
| S aureus | 4 | |
| E cloacae | 4 |
* Also, less frequently (<1%), Listeria species, Klebsiella species, group A Streptococcus, Staphylococcus epidermis, Streptococcus viridans, and N meningitidis
Older infants and children are at risk for bacteremia due to colonization of the nasopharynx or community-acquired organisms. Hib conjugate vaccine has decreased the prevalence of invasive Hib disease by 90% or more in industrialized countries.9 With the disappearance of Hib as a cause of occult bacteremia in children, the relative frequency of S Pneumoniae increased in some medical centers to more than 90%.37 Since the introduction and widespread use of the pneumococcal vaccines, the rate of vaccine-specific strains has dropped considerably, leading to significant changes in the patterns of causative organisms in more recent studies.
Table 4. Causes of Occult Bacteremia and Changes Over Time in Children Aged 3-36 Months with FWS4,2,8,11,17,26,20
Open table in new window
Table
| Organism* | 1975-1993, % | 1993, % | 1993-1996, % | 1990 to present, % |
|---|---|---|---|---|
| S pneumoniae | 83-86 | 93 | 92 | 89 |
| H influenzae type b | 5-13 | 2 | 0 | 0 |
| N meningitidis | 1-3 | … | … | … |
| Salmonella species | 1-7 | … | … | … |
| Organism* | 1975-1993, % | 1993, % | 1993-1996, % | 1990 to present, % |
|---|---|---|---|---|
| S pneumoniae | 83-86 | 93 | 92 | 89 |
| H influenzae type b | 5-13 | 2 | 0 | 0 |
| N meningitidis | 1-3 | … | … | … |
| Salmonella species | 1-7 | … | … | … |
* Also, less frequently (<1%), E coli, S aureus, Streptococcus pyogenes, group B Streptococcus, Moraxella species, Kingella species, Yersinia species, and Enterobacter species
The prevalence of occult bacteremia caused by pneumococcus has greatly decreased since the introduction of the 7-valent conjugate pneumococcal vaccine, which was designed to cover 98% of the strains of S pneumoniae responsible for occult bacteremia.19 A multicenter surveillance found that 82-94% of S pneumoniae invasive disease was caused by isolates that are contained in the 7-valent conjugate pneumococcal vaccine.23 Rates of heptavalent vaccine-serotype invasive pneumococcal infection postlicensure have dropped by 56%-100%, depending on location and age.38,39,40,41
S pneumoniae types 4, 6B, 9V, 14, 18C, 19F, and 23F are 98% covered by the 7-valent conjugate pneumococcal vaccine. The pattern of serotypes isolated from patients has undergone considerable change since the introduction of the pneumococcal vaccines. In the first few years of use, the number of cases decreased; more recently, the number of reports of nonvaccine strains replacing vaccine strains as causes of invasive pneumococcal infection has increased. In particular, strain 19A is a drug-resistant strain that has been highlighted in several studies, along with serotypes 15 and 33.42,43,41
More on Bacteremia |
Overview: Bacteremia |
| Differential Diagnoses & Workup: Bacteremia |
| Treatment & Medication: Bacteremia |
| Follow-up: Bacteremia |
| Multimedia: Bacteremia |
| References |
| Next Page » |
References
Spraycar M, ed. Stedman's Medical Dictionary. 26th ed. Baltimore, Md: Lippincott Williams & Wilkins; 1995.
Kuppermann N. Occult bacteremia in young febrile children. Pediatr Clin North Am. Dec 1999;46(6):1073-109. [Medline].
Kramer MS, Shapiro ED. Management of the young febrile child: a commentary on recent practice guidelines. Pediatrics. Jul 1997;100(1):128-34. [Medline].
Harper MB, Fleisher GR. Occult bacteremia in the 3-month-old to 3-year-old age group. Pediatr Ann. Aug 1993;22(8):484, 487-93. [Medline].
Lorin MI. Introduction and overview. Semin Pediatr Infect Dis. 1993;4:2-3.
Swindell SL, Chetham MM. Occult bacteremia. Fever without localizing signs: the problem of occult bacteremia. Semin Pediatr Infect Dis. 1993;4:24-29.
McCarthy PL. Fever. Pediatr Rev. Dec 1998;19(12):401-7; quiz 408. [Medline].
Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Agency for Health Care Policy and Research. Ann Emerg Med. Jul 1993;22(7):1198-210. [Medline].
Baraff LJ. Management of fever without source in infants and children. Ann Emerg Med. Dec 2000;36(6):602-14. [Medline].
Baraff LJ. Management of infants and children 3 to 36 months of age with fever without source. Pediatr Ann. Aug 1993;22(8):497-8, 501-4. [Medline].
Bass JW, Steele RW, Wittler RR, et al. Antimicrobial treatment of occult bacteremia: a multicenter cooperative study. Pediatr Infect Dis J. Jun 1993;12(6):466-73. [Medline].
Baker MD. Evaluation and management of infants with fever. Pediatr Clin North Am. Dec 1999;46(6):1061-72. [Medline].
Jaskiewicz JA, McCarthy CA. Evaluation and management of the febrile infant 60 days of age or younger. Pediatr Ann. Aug 1993;22(8):477-80, 482-3. [Medline].
Baraff LJ, Oslund SA, Schriger DL, et al. Probability of bacterial infections in febrile infants less than three months of age: a meta-analysis. Pediatr Infect Dis J. Apr 1992;11(4):257-64. [Medline].
Kadish HA, Loveridge B, Tobey J, et al. Applying outpatient protocols in febrile infants 1-28 days of age: can the threshold be lowered?. Clin Pediatr (Phila). Feb 2000;39(2):81-8. [Medline].
Baskin MN. The prevalence of serious bacterial infections by age in febrile infants during the first 3 months of life. Pediatr Ann. Aug 1993;22(8):462-6. [Medline].
Baraff LJ, Oslund S, Prather M. Effect of antibiotic therapy and etiologic microorganism on the risk of bacterial meningitis in children with occult bacteremia. Pediatrics. Jul 1993;92(1):140-3. [Medline].
Jones RG, Bass JW. Febrile children with no focus of infection: a survey of their management by primary care physicians. Pediatr Infect Dis J. Mar 1993;12(3):179-83. [Medline].
Alpern ER, Alessandrini EA, McGowan KL, et al. Serotype prevalence of occult pneumococcal bacteremia. Pediatrics. Aug 2001;108(2):E23. [Medline].
Lee GM, Harper MB. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med. Jul 1998;152(7):624-8. [Medline].
Lee GM, Fleisher GR, Harper MB. Management of febrile children in the age of the conjugate pneumococcal vaccine: a cost-effectiveness analysis. Pediatrics. Oct 2001;108(4):835-44. [Medline].
Black SB, Shinefield HR, Hansen J, et al. Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. Dec 2001;20(12):1105-7. [Medline].
Kaplan SL, Mason EO Jr, Wald E, et al. Six year multicenter surveillance of invasive pneumococcal infections in children. Pediatr Infect Dis J. Feb 2002;21(2):141-7. [Medline].
Giebink GS. The prevention of pneumococcal disease in children. N Engl J Med. Oct 18 2001;345(16):1177-83. [Medline].
Kupperman N, Malley R, Inkelis SH, et al. Clinical and hematologic features do not reliably identify children with unsuspected meningococcal disease. Pediatrics. 1999;103:E20.
Harper MB, Bachur R, Fleisher GR. Effect of antibiotic therapy on the outcome of outpatients with unsuspected bacteremia. Pediatr Infect Dis J. Sep 1995;14(9):760-7. [Medline].
Bauchner H, Pelton SI. Management of the young febrile child: a continuing controversy. Pediatrics. Jul 1997;100(1):137-8. [Medline].
Fleisher GR, Rosenberg N, Vinci R, et al. Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia. J Pediatr. Apr 1994;124(4):504-12. [Medline].
Strait RT, Kelly KJ, Kurup VP. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 levels in febrile, young children with and without occult bacteremia. Pediatrics. Dec 1999;104(6):1321-6. [Medline].
Dirnberger DR. Outpatient management of infants 28-60 days of age with fever without a source in a military setting. AAP Uniformed Services Section. 1996.
Levine OS, Farley M, Harrison LH, et al. Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics. Mar 1999;103(3):E28. [Medline].
Bass JW, Wittler RR, Weisse ME. Social smile and occult bacteremia. Pediatr Infect Dis J. Jun 1996;15(6):541. [Medline].
Bonadio WA. Defining fever and other aspects of body temperature in infants and children. Pediatr Ann. Aug 1993;22(8):467-8, 470-3. [Medline].
Baraff LJ, Schriger DL, Bass JW, et al. Management of the young febrile child. Commentary on practice guidelines. Pediatrics. Jul 1997;100(1):134-6. [Medline].
Mandl KD, Stack AM, Fleisher GR. Incidence of bacteremia in infants and children with fever and petechiae. J Pediatr. Sep 1997;131(3):398-404. [Medline].
Greenes DS, Harper MB. Low risk of bacteremia in febrile children with recognizable viral syndromes. Pediatr Infect Dis J. Mar 1999;18(3):258-61. [Medline].
Bass JW, Vincent JM, Demers DM. Oral antibiotic therapy for suspected occult bacteremia. J Pediatr. Dec 1994;125(6 Pt 1):1015-6. [Medline].
Hsu K, Pelton S, Karumuri S, et al. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. Pediatr Infect Dis J. Jan 2005;24(1):17-23. [Medline].
Black S, Shinefield H, Baxter R, et al. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J. Jun 2004;23(6):485-9. [Medline].
Black S, Shinefield H, Baxter R, et al. Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults. Vaccine. Apr 12 2006;24 Suppl 2:S2-79-80. [Medline].
Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. Apr 25 2007;297(16):1784-92. [Medline].
Pelton SI, Huot H, Finkelstein JA, et al. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J. Jun 2007;26(6):468-72. [Medline].
Hicks LA, Harrison LH, Flannery B, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis. Nov 1 2007;196(9):1346-54. [Medline].
Fernandez Lopez A, Luaces Cubells C, Garcia Garcia JJ, et al. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J. Oct 2003;22(10):895-903. [Medline].
Pulliam PN, Attia MW, Cronan KM. C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. Pediatrics. Dec 2001;108(6):1275-9. [Medline].
Lacour AG, Gervaix A, Zamora SA, et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs. Eur J Pediatr. Feb 2001;160(2):95-100. [Medline].
Isaacman DJ, Burke BL. Utility of the serum C-reactive protein for detection of occult bacterial infection in children. Arch Pediatr Adolesc Med. Sep 2002;156(9):905-9. [Medline].
Wack RP, Demers DM, Bass JW. Immature neutrophils in the peripheral blood smear of children with viral infections. Pediatr Infect Dis J. Mar 1994;13(3):228-30. [Medline].
Gendrel D, Raymond J, Coste J, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J. Oct 1999;18(10):875-81. [Medline].
Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J. Aug 1997;16(8):735-46; quiz 746-7. [Medline].
Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J. Aug 2000;19(8):679-87; quiz 688. [Medline].
Mariscalco MM. Is plasma procalcitonin ready for prime time in the pediatric intensive care unit?. Pediatr Crit Care Med. Jan 2003;4(1):118-9. [Medline].
Leclerc F, Cremer R, Noizet O. Procalcitonin as a diagnostic and prognostic biomarker of sepsis in critically ill children. Pediatr Crit Care Med. Apr 2003;4(2):264-6. [Medline].
Gendrel D, Raymond J, Assicot M, et al. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis. Jun 1997;24(6):1240-2. [Medline].
Bachur RG, Harper MB. Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics. Aug 2001;108(2):311-6. [Medline].
Herr SM, Wald ER, Pitetti RD, et al. Enhanced urinalysis improves identification of febrile infants ages 60 days and younger at low risk for serious bacterial illness. Pediatrics. Oct 2001;108(4):866-71. [Medline].
Bachur R, Perry H, Harper MB. Occult pneumonias: empiric chest radiographs in febrile children with leukocytosis. Ann Emerg Med. Feb 1999;33(2):166-73. [Medline].
Walson PD, Galletta G, Chomilo F, et al. Comparison of multidose ibuprofen and acetaminophen therapy in febrile children. Am J Dis Child. May 1992;146(5):626-32. [Medline].
Avner JR, Crain EF, Shelov SP. The febrile infant less than 10 days of age in the emergency department. Semin Pediatr Infect Dis. 1993;4:18-23.
Baker MD, Bell LM, Avner JR. Outpatient management without antibiotics of fever in selected infants. N Engl J Med. Nov 11 1993;329(20):1437-41. [Medline].
Baskin MN, O'Rourke EJ, Fleisher GR. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. J Pediatr. Jan 1992;120(1):22-7. [Medline].
Dagan R, Powell KR, Hall CB, et al. Identification of infants unlikely to have serious bacterial infection although hospitalized for suspected sepsis. J Pediatr. Dec 1985;107(6):855-60. [Medline].
Friedland IR. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J. Oct 1995;14(10):885-90. [Medline].
Rothrock SG, Harper MB, Green SM, et al. Do oral antibiotics prevent meningitis and serious bacterial infections in children with Streptococcus pneumoniae occult bacteremia? A meta-analysis. Pediatrics. Mar 1997;99(3):438-44. [Medline].
Pickering LK, ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003.
Nilsson P, Laurell MH. Carriage of penicillin-resistant Streptococcus pneumoniae by children in day-care centers during an intervention program in Malmo, Sweden. Pediatr Infect Dis J. Dec 2001;20(12):1144-9. [Medline].
Arditi M, Mason EO Jr, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics. Nov 1998;102(5):1087-97. [Medline].
Isaacman DJ, Kaminer K, Veligeti H, et al. Comparative practice patterns of emergency medicine physicians and pediatric emergency medicine physicians managing fever in young children. Pediatrics. Aug 2001;108(2):354-8. [Medline].
Nigrovic LE, Malley R. Evaluation of the febrile child 3 to 36 months old in the era of pneumococcal conjugate vaccine: focus on occult bacteremia. Clinical Pediatric Emergency Medicine. 2004;5.
Obaro SK, Adegbola RA, Banya WA, et al. Carriage of pneumococci after pneumococcal vaccination. Lancet. Jul 27 1996;348(9022):271-2. [Medline].
DeAngelis C, Joffe A, Wilson M, et al. Iatrogenic risks and financial costs of hospitalizing febrile infants. Am J Dis Child. Dec 1983;137(12):1146-9. [Medline].
Further Reading
Keywords
bacteriemia, occult bacteremia, fever without a source, FWS, occult bacteremia, bloodstream infection, serious bacterial infection, systemic bacterial infection, SBI, Streptococcus pneumoniae, pneumonia, meningitis, pneumococcal infection, pneumococcal meningitis, Neisseria meningitidis, Salmonella bacteremia, meningococcal bacteremia, hypothermia, hyperthermia, petechiae, urinary tract infection, UTI, Escherichia coli, E coli, antibiotic resistance, septic arthritis, osteomyelitis, cellulitis, otitis media, upper respiratory tract infection, hypotension, hypoperfusion, organ dysfunction, disseminated intravascular coagulation, deafness, mental retardation, seizures, paralysis, hypogammaglobulinemia, sickle cell anemia, HIV, malnutrition, asplenia, gastroenteritis, varicella, croup, gingivostomatitis, herpangina, bronchiolitis, rotavirus, enterovirus, respiratory syncytial virus
Overview: Bacteremia